Therapeutic Group: Cardiovascular Presentation Trocer® 2.6 SR Capsule: Each capsule contains Nitroglycerin sustained release pellets equivalent to Nitroglycerin USP 2.6 mg. Trocer® 2.6 SR Tablet: Each sustained release tablet contains Nitroglycerin BP 2.6 mg. Description Nitroglycerin SR is a potent coronary vasodilator. It also reduces venous return, lowers end-diastolic pressure in the right and left […]
Therapeutic Group: Anti Bacterial Presentation Nintoin tablet: Each tablet contains Nitrofurantoin USP 100 mg Nintoin SR Capsule: Each capsule contains Nitrofurantoin USP 100 mg Nintoin Suspension: Each 5 ml suspension contains Nitrofurantoin USP 25 mg Description Nitrofurantoin is an antibacterial agent specific for urinary tract infections. Nitrofurantoin is highly soluble in urine, to which it […]
Therapeutic Group: Anti Protozoal Presentation Nitazox tablet: Each tablet contains Nitazoxanide INN 500 mg . Nitazox Powder for Suspension: When reconstituted each 5 ml suspension contains Nitazoxanide INN 100 mg. Description Nitazox Oral Suspension contains the active ingredient Nitazoxanide, a synthetic antiprotozoal agent. Nitazoxanide is well absorbed from GIT. It interferes with Pyruvate Ferredoxin Oxidoreductase […]
Therapeutic Group: SARS-CoV-2 main protease (Mpro: also referred to as 3CLpro or nsp5 protease) inhibitor, and Ritonavir, an HIV-1 protease inhibitor and CYP3A inhibitor. Presentation Nirmatrelvir tablet: Each film-coated Nirmatrelvir tablet contains Nirmatrelvir INN 150 mg. Ritonavir tablet: Each film-coated Ritonavir tablet contains Ritonavir USP 100 mg Description Emergency Use Authorization (EUA) for the treatment […]
Therapeutic Group: Anti Cancer Presentation Ninacent 100: Each soft gel capsule contains Nintedanib Esylate INN equivalent to Nintedanib 100 mg. Ninacent 150: Each soft gel capsule contains Nintedanib Esylate INN equivalent to Nintedanib 150 mg. Description Nintedanib is a potent and selective multi-targeted receptor and non-receptor tyrosine kinase inhibitor that blocks platelet-derived growth factor receptor […]
Therapeutic Group: Cardiovascular Presentation Ridel ER 500: Each extended release tablet contains Niacin (nicotinic acid) USP 500 mg. Description Ridel tablet is a preparation of Niacin. It is proven effective at lowering VLDL, LDL, total cholesterol and triglyceride levels while raising HDL levels. So Niacin has been prescriped for the treatment of cardiovascular disease particularly […]
Therapeutic Group: protein kinase inhibitors Presentation Hercent TM 40: Each film coated tablet contains Neratinib Maleate INN eqv. to Neratinib 40 mg. Description Neratinib is a kinase inhibitor that irreversibly binds to Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and HER4. Neratinib is a member of the 4-anilino quinolidine class […]
Therapeutic Group: Ophthalmic Presentation Nepanil Sterile Ophthalmic Suspension:Each ml contains Nepafenac INN 1 mg. Description Nepanil is a sterile ophthalmic suspensions containing Nepafenac – a non steroidal anti-inflammatory drug (NSAID) for topical administration to the eyes. After instillation in the eye, it penetrates the cornea and is converted by ocular tissue hydrolase to Amfenac, a […]
Therapeutic Group: Anti Bacterial Presentation Nebazin Ointment: Each gram ointment contains Neomycin Sulphate BP 5mg and Bacitracin Zinc USP 500 IU. Description Nebazin Ointment is a combination of Neomycin Sulphate and Bacitracin Zinc for topical use in mixed infection of the skin and mucous membrane due to susceptible organisms. It has broad spectrum of activity. […]
Therapeutic Group: Analgesic, Anti Inflammatory Presentation Neforex Tablet: Each film coated tablet contains Nefopam Hydrochloride INN 30 mg. Neforex Injection: Each ampoule contains 1ml solution of Nefopam Hydrochloride INN 20 mg. Description Nefopam Hydrochloride is a centrally acting analgesic with a rapid onset of action. The main site of action appears to be in the […]